Bioiberica

What Bioiberica does

Bioiberica is a privately held global life sciences company headquartered in Barcelona, Spain, founded in 1975. It specializes in the identification, extraction, and manufacture of biologically derived active pharmaceutical ingredients (APIs) and functional ingredients from natural raw materials, organized into three business units: Human Health (pharmaceutical and nutraceutical), Animal Health (companion animal and livestock/aquaculture nutrition), and Plant Health (biostimulants for crop resilience). Its core technology centers on biomolecule extraction — notably native (undenatured) type II collagen (Collavant n2), hyaluronic acid (Mobilee), nucleotides (Nucleoforce), hydrolysed proteins (Palbio), and heparin — backed by over 50 granted patents and clinical evidence such as a 5.7% decrease in CTX-II cartilage biomarker vs 7.4% increase in placebo.

The company operates 9 production plants across Spain, Italy, Poland, Germany, the United States, Chile, and Brazil, exporting to 80+ countries. Bioiberica employs 251-500 people and reports a portfolio of 100+ products. It is the world's leading producer of heparin, an anticoagulant that the company states contributes to saving more than 100 million lives annually. Its business model is B2B ingredient supply: it sells APIs and branded functional ingredients to pharmaceutical, nutraceutical, functional food (e.g., Lactalis Spain's Puleva Vita Calcio Colagéno), and animal nutrition manufacturers, monetized through direct sales, licensing/royalty structures on proprietary ingredients, and one-time licensing of APIs. Distribution combines direct enterprise sales with regional channel partners (STAUBER in the US, ByHealth in China, Aska/Shintoa in Japan) and the May 2023 Biovall Heparin Science joint venture ($28.81M) with Vall Companys for sustainable heparin production from porcine intestinal mucosa co-products under a circular economy model. Recent strategic moves include the 2026 launch of a collagen-fortified dairy SKU in Spain, the 2026 NutraStrong Collagen Verified certification, and continued geographic expansion across the US, China, and Japan.

Name

Bioiberica

Legal name

BIOIBERICA S.A.U.

Website

https://bioiberica.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

251–500 employees

Short description

Bioiberica is a Barcelona-based global life sciences company that extracts and supplies biologically derived APIs and functional ingredients (heparin, collagen, hyaluronic acid, nucleotides, hydrolysed proteins) to pharmaceutical, nutraceutical, animal nutrition, and plant health manufacturers across 80+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Ingredients (Active Pharmaceutical Ingredients & Functional Ingredients)

NAICS

Medicinal and Botanical Manufacturing (325411), Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Medicinal Chemicals & Botanical Products (2833), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ), Antioxidants & Phytochemicals (Carotenoids, Tocopherols, Flavonoids, CoQ10, Resveratrol) (AFAJAKAI), Herbal & Botanical Supplements (CRADAGAD), Organic & Biological Input Retail (Biostimulants, Biopesticides, OMRI) (AFABAJAK)

Keywords

• Pharmaceutical ingredients
• Animal nutrition supplements
• Heparin production
• Nutraceutical ingredients
• Plant biostimulants

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices10 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical APIs (Active Pharmaceutical Ingredients): Bioiberica produces and supplies pharmaceutical-grade active ingredients including heparin, the leading anticoagulant for thrombosis prevention and treatment, contributing to saving over 100 million lives annually.
2. Branded Functional Ingredients: Sale of proprietary branded ingredients for nutraceutical and functional food applications including Collavant® n2 (collagen), Mobilee® (hyaluronic acid), Nucleoforce™ (nucleotides), and Palbio™ (hydrolysed proteins).
3. Animal Health Ingredients: Supply of ingredients for companion animal and livestock nutrition, including joint health ingredients for pets and nucleotide/hydrolysed protein solutions for farm animals.
4. Plant Health Solutions: Bioestimulants and agricultural solutions derived from amino acids to support crop resilience against heat stress and improve agricultural productivity.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

Bioiberica identifies, extracts, and manufactures biologically-derived active pharmaceutical ingredients (APIs) and functional branded ingredients for human health (heparin, native type II collagen Collavant n2, Mobilee hyaluronic acid, chondroitin sulfate), animal health and nutrition (Nucleoforce nucleotides, Palbio hydrolysed proteins), and plant health (amino acid-based biostimulants). The company operates 9 production plants across Spain, Italy, Poland, Germany, USA, Chile, and Brazil, exporting to over 80 countries.

Product overview

Bioiberica is a global Life Sciences company (headquartered in Palafolls, Barcelona, Spain; operating since 1975) that develops, manufactures, and markets biologically-derived active ingredients and pharmaceutical ingredients across three health segments: Human Health, Animal Health, and Plant Health. Its portfolio encompasses more than 100 products including APIs (heparin, chondroitin sulfate) and branded functional ingredients (Collavant® n2 native type II collagen, Mobilee® hyaluronic acid, Nucleoforce™ nucleotides, Palbio™ hydrolysed proteins). The company operates 9 production centres across Spain, Italy, Poland, Germany, USA, Chile, and Brazil, exporting to over 80 countries. Recent commercial moves include the launch of Puleva Vita Calcio Colagéno (a collagen-enriched milk with Lactalis Spain) and the expansion of Collavant® n2 certification (NutraStrong™ Collagen Verified) and distribution partnerships (Stauber in the US, ByHealth in China, Aska/Shintoa in Japan).

Differentiator

Problem solved

Functional benefit

Products and services

• Collavant n2 Native (undenatured) type II collagen ingredient designed to support joint health through oral tolerance mechanism. Clinically validated with demonstrated cartilage protection (5.7% decrease in CTX-II biomarker vs 7.4% increase in placebo). Effective at 40 mg daily dose in humans and 0.4 mg/day/kg in pets. Used in dietary supplements, functional foods, and pet nutrition products.
• Mobilee Patented hyaluronic acid matrix sourced from Bioiberica, used in joint health and beauty-from-within dietary supplements. Featured in products such as BioDynamix Joint Genesis.
• Nucleoforce (Nucleoforce Aqua and Nucleoforce Livestock) Balanced concentrate of free nucleotides and active precursors obtained from yeast, supporting immunological and intestinal health in farm animals and aquaculture species. Distributed in Japan through partnerships with Aska Animal Health Co. and Shintoa Corporation.
• Palbio (Palbio 50 RD and Palbio 50 Plus) Safe source of high-quality hydrolysed proteins in the form of L-α-amino acids and bioactive peptides. Supports intestinal health of young animals, improving digestion and feed intake. Already authorised in more than 40 countries. Includes a six-level safety control system capable of inactivating African Swine Fever virus.
• Heparin (Biovall Heparin Science) Pharmaceutical-grade heparin API, the leading anticoagulant for prevention and treatment of thrombosis. Bioiberica is the world leader in heparin production, contributing to saving over 100 million lives annually.
• Chondroitin Sulfate Active pharmaceutical ingredient used in osteoarthritis treatment, nutraceuticals, pharmaceuticals, and pet health products. Part of Bioiberica's portfolio sold across global markets.
• Bioiberica API & Branded Ingredients Portfolio Portfolio of more than 100 products spanning APIs (Active Pharmaceutical Ingredients) and functional branded ingredients for pharmaceutical, nutraceutical, veterinary, agricultural, and animal nutrition sectors. Includes collagens, hyaluronic acid, nucleotides, hydrolyzed proteins, and heparin. Exporting to over 80 countries.
• Puleva Vita Calcio Colagéno Collagen-enriched functional milk beverage co-developed with Lactalis Spain, enriched with native type II collagen (Collavant n2) at 40 mg daily dose for joint health support. First collagen-fortified dairy drink in Spain's mainstream market.

Quantifiable outcome

• 5.7% decrease in CTX-II biomarker (cartilage protection) vs 7.4% increase in placebo group with 40mg daily Collavant n2
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered flagship, core and supporting.

• Lactalis SpainflagshipStrategic or Co-development Partner · 20 January 2026Strategic partnership to launch Puleva Vita Calcio Colagéno, the first collagen-enriched functional milk beverage in Spain's mainstream market. Product features native type II collagen (Collavant n2) at 40mg daily dose for joint health support, formulated to withstand UHT processing. Marked the first collagen-fortified milk drink in Spain and represents a blueprint for integrating bioactive ingredients into commercial products.
• STAUBERcoreChannel Partner/ Reseller/ Distributor · 11 February 2025Strategic partnership to expand distribution of Bioiberica's branded ingredients for mobility and beauty-from-within applications to the US nutraceuticals market. STAUBER serves as official distributor in the United States for these product lines.
• Vall CompanysflagshipStrategic or Co-development Partner · 1 May 2023$28.81 million joint venture called Biovall Heparin Science to produce sustainable heparin from porcine intestinal mucosa co-products. Represents significant investment in circular economy approach to heparin production, transforming co-products into high-value pharmaceutical ingredients.
• NABIHEAL Consortium (Horizon Europe)coreStrategic or Co-development Partner · 18 January 2023European project funded by Horizon Europe programme coordinated by CIBER to develop innovative multifunctional biomaterials for complex wound treatments using affordable EU-based manufacturing technologies. Bioiberica contributes knowledge of biologically-derived ingredients for biomaterial development. Consortium includes 14 partners from 7 countries including research centers, universities, and private companies.
• ByHealthcoreStrategic or Co-development Partner · 11 March 2022Partnership to develop ByHealth's Highflex type II collagen tablets using Bioiberica's Collavant n2 for joint health solutions in China. Product addresses growing number of physically active consumers seeking joint health solutions and marks first product from strategic partnership, boosting ByHealth's leading joint health brand position in China.
• Aska Animal Health Co.coreChannel Partner/ Reseller/ Distributor · 1 January 2020Official distributor in Japan for Bioiberica's Nucleoforce Aqua and Nucleoforce Livestock ingredients. Aska manages important regulatory procedures and local R&D trials, supporting Bioiberica in reaching customers across Japan with animal nutrition solutions.
• Shintoa CorporationcoreChannel Partner/ Reseller/ Distributor · 1 January 2020Distribution partner in Japan overseeing promotion and sale of Bioiberica's Nucleoforce ingredients. Partner with Aska Animal Health to enable widespread distribution and marketing of highly effective raw materials while strengthening Bioiberica's position in Asia.
• SGS NutrasourcesupportingOthersDeveloper of NutraStrong™ Collagen Verified certification program - the first independent certification system dedicated specifically to collagen. Certifies collagen identity, traceable origin, manufacturing safety, and quality claims.

Scale indicators8 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Rousselot (Darling Ingredients): World-leading manufacturer of gelatin and collagen peptides serving pharmaceutical, nutraceutical, and food applications. Comparable to Bioiberica in collagen-based ingredients for joint health and as a supplier of pharma-grade gelatins, with similar regulatory and B2B ingredient business model.
• PB Leiner (Tessenderlo Group): Global producer of gelatin, collagen peptides, and bioactive ingredients for food, nutraceutical, and pharma markets. Directly comparable to Bioiberica in collagen-based functional ingredients and shares the B2B ingredient manufacturer business model serving consumer health brands.
• Bioiberica competitor: Yantai Dongcheng Biochemicals (heparin): Chinese heparin API manufacturer and one of the largest global producers of low-molecular-weight heparin. Directly competes with Bioiberica in the heparin API market, with overlapping pharmaceutical customers and similar B2B API business model.
• GELITA: German-headquartered global leader in collagen peptides, gelatin, and bioactive collagen protein ingredients for nutraceutical and pharmaceutical applications. Directly comparable to Bioiberica's collagen and hydrolysed protein portfolio (Collavant, Palbio) and competes in the same joint health and functional nutrition categories.
• Weishardt: French-headquartered gelatin and collagen peptide producer for nutraceutical, food, and pharmaceutical applications. Similar scale and product overlap to Bioiberica's hydrolysed protein and collagen ingredients.
• Bioiberica competitor: Nanjing King-friend Biochemical Pharmaceutical (heparin): Leading Chinese heparin and enoxaparin sodium API manufacturer with global distribution. Comparable to Bioiberica as a major heparin API supplier competing in the same pharmaceutical supply chain for anticoagulants.

Broad incumbents

• Croda International: British specialty chemicals company with a significant life sciences and consumer care ingredients business. Overlaps with Bioiberica in pharmaceutical excipients, bioactive ingredients, and personal care/beauty-from-within applications as part of a much wider portfolio.
• Glanbia Nutritionals: Global nutrition solutions provider with a large ingredients portfolio serving dietary supplement, functional food, and animal nutrition customers. Comparable to Bioiberica as a B2B ingredient supplier with branded ingredient offerings and multi-vertical reach.
• dsm-firmenich (Animal Nutrition & Health): Global science-based company in nutrition, health, and beauty. Overlaps with Bioiberica in animal nutrition ingredients, vitamin premixes, and functional nutrition bioactive ingredients as part of a much broader portfolio, with a comparable emphasis on science-backed B2B ingredients.
• Kerry Group: Global taste and nutrition company supplying ingredients and functional solutions to food, beverage, and supplement manufacturers. Comparable to Bioiberica in functional nutrition ingredients (proteins, bioactive peptides) and as a B2B partner to consumer health brands like Lactalis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Bioiberica
• LinkedInlinkedin.com/company/bioiberica-sau

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioiberica